AAAAAA

   
Results: 1-8 |
Results: 8
Synthesis and study of a cyclic angiotensin II antagonist analogue revealsthe role of pi-pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists
Authors: Polevaya, L Mavromoustakos, T Zoumboulakis, P Grdadolnik, SG Roumelioti, P Giatas, N Mutule, I Keivish, T Vlahakos, DV Iliodromitis, EK Kremastinos, DT Matsoukas, J
Citation: L. Polevaya et al., Synthesis and study of a cyclic angiotensin II antagonist analogue revealsthe role of pi-pi* interactions in the C-terminal aromatic residue for agonist activity and its structure resemblance with AT(1) non-peptide antagonists, BIO MED CH, 9(6), 2001, pp. 1639-1647
The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine
Authors: Lindblom, J Opmane, B Mutulis, F Mutule, I Petrovska, R Klusa, V Bergstrom, L Wikberg, JES
Citation: J. Lindblom et al., The MC4 receptor mediates alpha-MSH induced release of nucleus accumbens dopamine, NEUROREPORT, 12(10), 2001, pp. 2155-2158
Design of new small, cyclic melanocortin receptor-binding peptides using molecular modelling: Role of the His residue in the melanocortin peptide core
Authors: Prusis, P Muceniece, R Mutule, I Mutulis, F Wikberg, JES
Citation: P. Prusis et al., Design of new small, cyclic melanocortin receptor-binding peptides using molecular modelling: Role of the His residue in the melanocortin peptide core, EUR J MED C, 36(2), 2001, pp. 137-146
Detection of regions in the MC1 receptor of importance for the selectivityof the MC1 receptor super-selective MS04/MS05 peptides
Authors: Muceniece, R Mutule, I Mutulis, F Prusis, P Szardenings, M Wikberg, JES
Citation: R. Muceniece et al., Detection of regions in the MC1 receptor of importance for the selectivityof the MC1 receptor super-selective MS04/MS05 peptides, BBA-PROT ST, 1544(1-2), 2001, pp. 278-282
New highly specific agonistic peptides for human melanocortin MC1 receptor
Authors: Szardenings, M Muceniece, R Mutule, I Mutulis, F Wikberg, JES
Citation: M. Szardenings et al., New highly specific agonistic peptides for human melanocortin MC1 receptor, PEPTIDES, 21(2), 2000, pp. 239-243
Thyrotropin releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor
Authors: Schioth, HB Prusis, P Muceniece, R Mutulis, F Mutule, I Wikberg, JES
Citation: Hb. Schioth et al., Thyrotropin releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor, PEPTIDES, 20(3), 1999, pp. 395-400
Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119
Authors: Schioth, HB Muceniece, R Mutulis, F Bouifrouri, AA Mutule, I Wikberg, JES
Citation: Hb. Schioth et al., Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119, NEUROPEPTID, 33(3), 1999, pp. 191-196
Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist
Authors: Skuladottir, GV Jonsson, L Skarphedinsson, JO Mutulis, F Muceniece, R Raine, A Mutule, I Helgason, J Prusis, P Wikberg, JES Schioth, HB
Citation: Gv. Skuladottir et al., Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist, BR J PHARM, 126(1), 1999, pp. 27-34
Risultati: 1-8 |